Patents by Inventor Francesco Bistoni

Francesco Bistoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of infections with alpha thymosin peptides
    Patent number: 8389680
    Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: March 5, 2013
    Assignee: SciClone Pharmaceuticals, Inc.
    Inventors: Guido Rasi, Enrico Garaci, Francesco Bistoni, Luigina Romani, Paolo Di Francesco
  • Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
    Patent number: 8337828
    Abstract: It is described the use of thymosin alpha 1 in combination with long pentraxin PTX3 or Ganciclovir, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Grant
    Filed: April 12, 2007
    Date of Patent: December 25, 2012
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Luigina Romani, Francesco Bistoni, Enrico Garaci
  • TREATMENT OF ASPERGILLUS INFECTIONS WITH ALPHA THYMOSIN PEPTIDES
    Publication number: 20120295840
    Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
    Type: Application
    Filed: May 29, 2012
    Publication date: November 22, 2012
    Applicant: SCICLONE PHARMACEUTICALS, INC.
    Inventors: Guido RASI, Enrico GARACI, Francesco BISTONI, Luigina ROMANI, Paolo Di Francesco
  • Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
    Patent number: 8268304
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Grant
    Filed: February 15, 2011
    Date of Patent: September 18, 2012
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite SpA
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • Treatment of infections with alpha thymosin peptides
    Patent number: 8207294
    Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
    Type: Grant
    Filed: March 29, 2004
    Date of Patent: June 26, 2012
    Assignee: SciClone Pharmaceuticals, Inc.
    Inventors: Guido Rasi, Enrico Garaci, Francesco Bistoni, Luigina Romani, Paolo Di Francesco
  • Use of thymosin alpha 1 for the treatment of immunological diseases
    Patent number: 8022036
    Abstract: It is described the use of thymosin alpha 1 for preparing a medicament useful for the prevention or treatment of graft-versus-host disease or graft rejection reactions in organ transplantation, in a mammal subject, in which the cells, tissues or organs for transplant is selected from the group comprising: stem cells, hematopoietic stem cells, bone marrow, heart, liver, kidney, lung, pancreas, small intestine, cornea or skin.
    Type: Grant
    Filed: November 17, 2008
    Date of Patent: September 20, 2011
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Luigina Romani, Francesco Bistoni, Enrico Garaci
  • USE OF THE LONG PENTRAXIN PTX3 FOR THE PREVENTION OR TREATMENT OF VIRAL DISEASES
    Publication number: 20110224132
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Application
    Filed: February 15, 2011
    Publication date: September 15, 2011
    Applicant: TECNOGEN S.P.A
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
    Patent number: 7910092
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: March 22, 2011
    Assignee: Tecnogen S.p.A.
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20100004174
    Abstract: The invention concerns the use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases such as multiple sclerosis, and inflammatory bowel diseases such as Crohn's disease or ulcerative colitis.
    Type: Application
    Filed: September 27, 2007
    Publication date: January 7, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE
    Inventors: Luigina Romani, Francesco Bistoni, Enrico Garaci, Guido Rasi, Paola Sinbaldi Vallebona
  • USE OF THE LONG PENTRAXIN PTX3 FOR THE PREVENTION OR TREATMENT OF VIRAL DISEASES
    Publication number: 20090286726
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Application
    Filed: February 28, 2007
    Publication date: November 19, 2009
    Applicant: TECNOGEN S.P.A.
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • USE OF THYMOSIN ALPHA 1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
    Publication number: 20090275508
    Abstract: It is described the use of thymosin alpha 1 in combination with long pentraxin PTX3 or Ganciclovir, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Application
    Filed: April 12, 2007
    Publication date: November 5, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Luigina Romani, Francesco Bistoni, Enrico Garaci
  • USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ALLERGIES
    Publication number: 20090270594
    Abstract: The invention concerns the use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies
    Type: Application
    Filed: September 27, 2007
    Publication date: October 29, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE
    Inventors: Luigina Romani, Francesco Bistoni, Enrico Garaci, Guido Rasi, Paola Sinibaldi Vallebona
  • USE OF THYMOSIN ALPHA 1 FOR THE TREATMENT OF IMMUNOLOGICAL DISEASES
    Publication number: 20090155260
    Abstract: It is described the use of thymosin alpha 1 for preparing a medicament useful for the prevention or treatment of graft-versus-host disease or graft rejection reactions in organ transplantation, in a mammal subject, in which the cells, tissues or organs for transplant is selected from the group comprising: stem cells, hematopoietic stem cells, bone marrow, heart, liver, kidney, lung, pancreas, small intestine, cornea or skin.
    Type: Application
    Filed: November 17, 2008
    Publication date: June 18, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Luigina ROMANI, Francesco BISTONI, Enrico GARACI
  • Treatment of aspergillus infections with alpha thymosin peptides
    Publication number: 20070129292
    Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
    Type: Application
    Filed: March 29, 2004
    Publication date: June 7, 2007
    Applicant: SciClone Pharmaceuticals, Inc.
    Inventors: Guido Rasi, Enrico Garaci, Francesco Bistoni, Luigina Romani, Paolo Di Francesco